DrugNov 13, 2019
Basic Reset CBD Reset 2400, True Full Spectrum Natural (unflavored), 2400 mg CBD, 1 fl. oz. recall — FDA D-0194-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 164
10,685 detailed records are currently available in this category.
DrugNov 6, 2019
Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose recall — FDA D-0167-2020
Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate…
Class IIIFDA: TerminatedArbor Pharmaceuticals Inc.
DrugNov 6, 2019
Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension recall — FDA D-0162-2020
Labeling: Incorrect or missing package insert.
Class IIIFDA: TerminatedSandoz Inc.
DrugNov 6, 2019
Nephron Pharmaceuticals Corporation dba Nephron PF-Succinylcholine Chloride Injection, USP recall — FDA D-0154-2020
Incorrect labeling: Incorrect or missing lot and/or exp date
Class IIIFDA: TerminatedNephron Pharmaceuticals Corporation dba Nephron…
DrugNov 6, 2019
Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL) recall — FDA D-0299-2020
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 6, 2019
Estradiol Vaginal Inserts USP, 10 mcg recall — FDA D-0156-2020
Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.
Class IIFDA: TerminatedGlenmark Pharmaceuticals Inc., USA
DrugNov 6, 2019
Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only recall — FDA D-0163-2020
Labeling: Incorrect or missing package insert.
Class IIIFDA: TerminatedSandoz Inc.
DrugNov 6, 2019
FITOTERAPIA USA Mero Macho Artificially Flavored Passion Fruit Vitamin C Liquid Supplement recall — FDA D-0320-2020
Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.
Class IFDA: TerminatedFITOTERAPIA USA, Inc.
DrugNov 6, 2019
IBUPROFEN Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free recall — FDA D-0301-2020
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 6, 2019
Atorvastatin Calcium Tablets, USP 40 mg*, 1,000 count bottles recall — FDA D-0153-2020
Presence of Foreign Tablets/Capsules: a single tablet of Pravastatin 40 mg found in bottle of Atorvastatin Calcium 40 mg.
Class IIIFDA: TerminatedApotex Inc.
DrugNov 6, 2019
Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL) recall — FDA D-0298-2020
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 6, 2019
Bimatoprost Ophthalmic Solution 0.03% recall — FDA D-0161-2020
Labeling: Incorrect or missing package insert.
Class IIIFDA: TerminatedSandoz Inc.
DrugNov 6, 2019
Taro Pharmaceuticals U.S.A Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry recall — FDA D-0302-2020
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 6, 2019
IBUPROFEN Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free recall — FDA D-0300-2020
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 6, 2019
AuroMedics Pharma Ranitidine Tablets USP,150 mg, 8-count bottles recall — FDA D-0166-2020
CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
Class IIIFDA: OngoingAuroMedics Pharma LLC
DrugOct 30, 2019
Nephron Pharmaceuticals Corporation dba Nephron Amino Acid Injection 50 g/1000 mL (50 mg/mL) recall — FDA D-0150-2020
Lack of Assurance of Sterility; bags have potential to leak
Class IIFDA: TerminatedNephron Pharmaceuticals Corporation dba Nephron…
DrugOct 30, 2019
Nephron Pharmaceuticals Corporation dba Nephron PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine recall — FDA D-0148-2020
GMP Deviations: potential glass contamination
Class IIFDA: TerminatedNephron Pharmaceuticals Corporation dba Nephron…
DrugOct 30, 2019
Nephron Pharmaceuticals Corporation dba Nephron PF-Fentanyl Citrate (2 mcg/mL)* & recall — FDA D-0147-2020
GMP Deviations: potential glass contamination
Class IIFDA: TerminatedNephron Pharmaceuticals Corporation dba Nephron…
DrugOct 30, 2019
Nephron Pharmaceuticals Corporation dba Nephron PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine recall — FDA D-0149-2020
GMP Deviations: potential glass contamination
Class IIFDA: TerminatedNephron Pharmaceuticals Corporation dba Nephron…
DrugOct 23, 2019
Atlas Pharmaceuticals Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial recall — FDA D-0144-2020
Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.
Class IIFDA: TerminatedAtlas Pharmaceuticals, LLC
DrugOct 23, 2019
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and recall — FDA D-0143-2020
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Class IIFDA: TerminatedAurobindo Pharma USA Inc.
DrugOct 23, 2019
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles recall — FDA D-0140-2020
Superpotent
Class IIFDA: TerminatedMacleods Pharma Usa Inc.
DrugOct 23, 2019
Jubilant Cadista Pharmaceuticals Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg recall — FDA D-0145-2020
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
Class IIFDA: TerminatedJubilant Cadista Pharmaceuticals, Inc.
DrugOct 16, 2019
LMD IN DEXTROSE 10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 recall — FDA D-0136-2020
Lack of Assurance of Sterility: Bag has the potential to leak.
Class IIFDA: TerminatedPfizer Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.